Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLOTOX: Botox for Gait in Chronic Hemiparetic Patients
NCT01821573Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2013
- Primary completion
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01821573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821573.